Operations

>

Latest News

Catalent Cuts 350 Jobs at Baltimore Site Amid Customer Demand Shift
Catalent Cuts 350 Jobs at Baltimore Site Amid Customer Demand Shift

August 20th 2025

The company is downsizing its gene therapy operations following reduced demand from a major client, even as industry reliance on CDMOs and CMOs for capacity and expertise continues to grow.

Going Beyond Compliance: Early Adoption of FDA’s Quality Management Maturity Program—and the Practical Considerations for Executives
Going Beyond Compliance: Early Adoption of FDA’s Quality Management Maturity Program—and the Practical Considerations for Executives

August 18th 2025

Navigating Divergent Currents: Biopharma Review and Outlook
Navigating Divergent Currents: Biopharma Review and Outlook

August 15th 2025

Stock.adobe.com
Can AI Accelerate Clinical Review at FDA?

July 23rd 2025

How Does the Shift to Early-Stage M&A Change Due Diligence?
How Does the Shift to Early-Stage M&A Change Due Diligence?

May 12th 2025

Video Interviews
Podcasts

More News

Bridging the Gap: A Large Pharma Blueprint

Bridging the Gap: A Large Pharma Blueprint

David Kamenir
May 9th 2025

Five steps for organizations in bringing enterprise-level strategies to life.

Asembia 2025: What Pharma Leaders Must Know About Tariffs, Supply Chains, and Policy Changes

Asembia 2025: What Pharma Leaders Must Know About Tariffs, Supply Chains, and Policy Changes

Don Tracy, Associate Editor
May 1st 2025

The Zensights Federated Healthcare Advisory Panel explores how shifting global dynamics are reshaping access and strategic planning across the healthcare system.

Novartis to Invest $23 Billion in US Manufacturing and R&D Over Five Years

Novartis to Invest $23 Billion in US Manufacturing and R&D Over Five Years

Don Tracy, Associate Editor
April 11th 2025

Investment is expected to bring approximately 1,000 new jobs at Novartis and 4,000 additional roles across the United States.

Pharmaceutical Industry Avoids Trump’s Tariffs — For Now

Pharmaceutical Industry Avoids Trump’s Tariffs — For Now

PharmExec Staff
April 4th 2025

Eli Lilly CEO David Ricks to the BBC: “It feels like it'll be hard to come back from here."

Biogen to Establish New Global HQ and Innovation Hub in Massachusetts by 2028

Biogen to Establish New Global HQ and Innovation Hub in Massachusetts by 2028

Don Tracy, Associate Editor
March 24th 2025

The facility, which is set to open amid Biogen’s 50th anniversary, will integrate research and development, technical operations, and commercial teams into one location.

Johnson & Johnson to Invest Over $55 Billion in US Manufacturing Facilities

Johnson & Johnson to Invest Over $55 Billion in US Manufacturing Facilities

Don Tracy, Associate Editor
March 21st 2025

The investment, which is a 25% increase from previous years, will support three new advanced manufacturing facilities, expansions at existing sites, and R&D efforts.